114 related articles for article (PubMed ID: 19262431)
1. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Hosseini H; Khalili MR; Nowroozizadeh S
Retina; 2009 Apr; 29(4):562. PubMed ID: 19262431
[No Abstract] [Full Text] [Related]
2. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Nowroozzadeh MH
Retina; 2009 Apr; 29(4):564-5; author reply 565-8. PubMed ID: 19262428
[No Abstract] [Full Text] [Related]
3. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Mintz-Hittner HA; Kuffel RR
Retina; 2008 Jun; 28(6):831-8. PubMed ID: 18536599
[TBL] [Abstract][Full Text] [Related]
4. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P; Kychenthal A
Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
[TBL] [Abstract][Full Text] [Related]
5. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
Kychenthal A; Dorta P
Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
[TBL] [Abstract][Full Text] [Related]
6. Off-label use of bevacizumab in retinopathy of prematurity.
Rishi E; Rishi P; Ratra D; Bhende M
Retina; 2009 Feb; 29(2):284; author reply 284-5. PubMed ID: 18854784
[No Abstract] [Full Text] [Related]
7. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
8. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
Nonobe NI; Kachi S; Kondo M; Takai Y; Takemoto K; Nakayama A; Hayakawa M; Terasaki H
Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
[TBL] [Abstract][Full Text] [Related]
9. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.
Kong L; Mintz-Hittner HA; Penland RL; Kretzer FL; Chévez-Barrios P
Arch Ophthalmol; 2008 Aug; 126(8):1161-3. PubMed ID: 18695118
[No Abstract] [Full Text] [Related]
10. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
Azad R; Chandra P
Indian J Ophthalmol; 2007; 55(4):319; author reply 320. PubMed ID: 17595491
[No Abstract] [Full Text] [Related]
12. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
Kim J; Kim SJ; Chang YS; Park WS
Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
[TBL] [Abstract][Full Text] [Related]
13. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
[TBL] [Abstract][Full Text] [Related]
14. Reply: Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Mintz-Hittner HA
Retina; 2009 Apr; 29(4):562-4. PubMed ID: 26281628
[No Abstract] [Full Text] [Related]
15. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
Travassos A; Teixeira S; Ferreira P; Regadas I; Travassos AS; Esperancinha FE; Prieto I; Pires G; van Velze R; Valido A; Machado Mdo C
Ophthalmic Surg Lasers Imaging; 2007; 38(3):233-7. PubMed ID: 17552391
[TBL] [Abstract][Full Text] [Related]
16. Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity.
Shah PK; Morris RJ; Narendran V; Kalpana N
Indian J Ophthalmol; 2011; 59(1):73-4. PubMed ID: 21157086
[No Abstract] [Full Text] [Related]
17. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.
Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK
Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
[TBL] [Abstract][Full Text] [Related]
19. A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
Patel CK; Walker NJ; Kam JK
Br J Ophthalmol; 2010 Aug; 94(8):1107-9. PubMed ID: 20558426
[No Abstract] [Full Text] [Related]
20. Bevacizumab (avastin) for the treatment of retinopathy of prematurity.
Beaulieu MJ
Neonatal Netw; 2012; 31(4):242-7. PubMed ID: 22763251
[No Abstract] [Full Text] [Related]
[Next] [New Search]